BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10832076)

  • 1. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia.
    Pi J; Kumagai Y; Sun G; Yamauchi H; Yoshida T; Iso H; Endo A; Yu L; Yuki K; Miyauchi T; Shimojo N
    Free Radic Biol Med; 2000 Apr; 28(7):1137-42. PubMed ID: 10832076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased nitric oxide production in the rat brain after chronic arsenic exposure.
    Zarazúa S; Pérez-Severiano F; Delgado JM; Martínez LM; Ortiz-Pérez D; Jiménez-Capdeville ME
    Neurochem Res; 2006 Aug; 31(8):1069-77. PubMed ID: 16871439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced XOR activity in eNOS-deficient mice: Effects on the nitrate-nitrite-NO pathway and ROS homeostasis.
    Peleli M; Zollbrecht C; Montenegro MF; Hezel M; Zhong J; Persson EG; Holmdahl R; Weitzberg E; Lundberg JO; Carlström M
    Free Radic Biol Med; 2016 Oct; 99():472-484. PubMed ID: 27609225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.
    Lauer T; Preik M; Rassaf T; Strauer BE; Deussen A; Feelisch M; Kelm M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12814-9. PubMed ID: 11606734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fusion of field and laboratory studies on the investigation of arsenic].
    Kumagai Y
    Yakugaku Zasshi; 2009 Oct; 129(10):1177-85. PubMed ID: 19797872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evidence for lead-induced inhibition of nitric oxide formation.
    Barbosa F; Sertorio JT; Gerlach RF; Tanus-Santos JE
    Arch Toxicol; 2006 Dec; 80(12):811-6. PubMed ID: 16670857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water.
    Pi J; Yamauchi H; Kumagai Y; Sun G; Yoshida T; Aikawa H; Hopenhayn-Rich C; Shimojo N
    Environ Health Perspect; 2002 Apr; 110(4):331-6. PubMed ID: 11940449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biochemical changes in chronic arsenic poisoning among Bangladeshi patients.
    Nabi AH; Rahman MM; Islam LN
    Int J Environ Res Public Health; 2005 Dec; 2(3-4):385-93. PubMed ID: 16819093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum nitrite and nitrate concentrations in children with the sepsis syndrome.
    Wong HR; Carcillo JA; Burckart G; Shah N; Janosky JE
    Crit Care Med; 1995 May; 23(5):835-42. PubMed ID: 7736740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of a nitric oxide synthase inhibitor counteracts prostaglandin F2-induced luteolysis in cattle.
    Skarzynski DJ; Jaroszewski JJ; Bah MM; Deptula KM; Barszczewska B; Gawronska B; Hansel W
    Biol Reprod; 2003 May; 68(5):1674-81. PubMed ID: 12606417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in serum thioredoxin among individuals chronically exposed to arsenic in drinking water.
    Li Y; Gao Y; Zhao L; Wei Y; Feng H; Wang C; Wei W; Ding Y; Sun D
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):124-32. PubMed ID: 22202168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico.
    Meza MM; Kopplin MJ; Burgess JL; Gandolfi AJ
    Environ Res; 2004 Oct; 96(2):119-26. PubMed ID: 15325872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats.
    Ríos R; Zarazúa S; Santoyo ME; Sepúlveda-Saavedra J; Romero-Díaz V; Jiménez V; Pérez-Severiano F; Vidal-Cantú G; Delgado JM; Jiménez-Capdeville ME
    Toxicology; 2009 Jun; 261(1-2):68-75. PubMed ID: 19409443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction.
    Kumagai Y; Pi J
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):450-7. PubMed ID: 15276426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide in streptozotocin-induced diabetes mellitus in rats.
    Maree A; Peer G; Iaina A; Blum M; Wollman Y; Csernihovsky T; Silverberg DS; Cabili S
    Clin Sci (Lond); 1996 May; 90(5):379-84. PubMed ID: 8665775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.
    Dooley A; Gao B; Bradley N; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
    Rheumatology (Oxford); 2006 Jun; 45(6):676-84. PubMed ID: 16399843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview on chronic arsenism via drinking water in PR China.
    Xia Y; Liu J
    Toxicology; 2004 May; 198(1-3):25-9. PubMed ID: 15138026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral vascular diseases resulting from chronic arsenical poisoning.
    Yu HS; Lee CH; Chen GS
    J Dermatol; 2002 Mar; 29(3):123-30. PubMed ID: 11990246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic arsenic poisoning in drinking water in Inner Mongolia and its associated health effects.
    Guo JX; Hu L; Yand PZ; Tanabe K; Miyatalre M; Chen Y
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1853-8. PubMed ID: 17952786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.